Indication
Glucocorticoid Resistant ICIs-related Myocarditis
1 clinical trial
1 product
Clinical trial
The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis: a Single-arm, Prospective, Phase 2 TrialStatus: Not yet recruiting, Estimated PCD: 2025-11-30
Product
Tofacitinib